Effect of Ascorbic Acid on Postoperative Acute Kidney Injury in Coronary Artery Bypass Graft Patients: A Pilot Study


  • Miha Antonic Department of Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia




ascorbic acid, vitamin C, acute kidney injury, coronary artery bypass grafting, cardiopulmonary bypass


Background: Even minor postoperative reductions in renal function influence the outcome of cardiac surgery. The mechanisms of postoperative renal injury in cardiac surgery are multifactorial and include ischemia-reperfusion injury. The study investigates the effect of the antioxidant ascorbic acid on the postoperative acute kidney injury after elective CABG surgery.

Methods: A prospective randomized single-center trial was conducted in on-pump coronary artery bypass patients. The patients in the ascorbic acid group received 2 grams of ascorbic acid 24 hours and 2 hours preoperatively and 1 gram twice daily five days after the surgery.  Postoperatively, the subjects were monitored for renal dysfunction and
other complications.

Results: 100 patients were included, with 50 patients in each study group. The groups were well matched for baseline demographics, preoperative medications, comorbidities, and had similar intraoperative characteristics. The incidence of postoperative acute kidney injury in the ascorbic acid group was 16% and 14% in the control group (P = .779). The groups also did not differ in peak postoperative serum creatinine
(83 [33] µmol/L versus 83 [39] µmol/L; P = .434), the lowest postoperative creatinine clearance (96.40 ± 35.78 mL/min versus 90.89 ± 36.18 mL/min; P = .766), and time from surgery to the onset of peak postoperative serum creatinine
(1.64 ± 1.34 days versus 1.92 ± 1.54 days; P = .393). There was no dialysis required in any patient. 

Conclusion: The results of this study did not demonstrate a significant protective effect of ascorbic acid on the incidence of postoperative acute renal injury in elective on-pump CABG patients.

Author Biography

Miha Antonic, Department of Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia

Dept. for Cardiac Surgery Staff Surgeon


Antonic M, Gersak B. 2007. Renal function after port access and median sternotomy mitral valve surgery. Heart Surg Forum 10:E401-7.

Bjordahl PM, Helmer SD, Gosnell DJ, Wemmer GE, O’Hara W, Milfeld DJ. 2012. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am J Surg 204:862-7.

Bove T, Calabro MG, Landoni G, Aletti G, Marino G, Crescenzi G. 2004. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 18:442-5.

Briguori C, Airoldi F, D’Andrea D, et al. 2007. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115:1211-7.

Brown JR, Kramer RS, Coca SG, Parikh CR. 2010. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 90:1142-9.

Cockcroft DW, Gault MH. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.

Eslami M, Sattarzadeh Badkoubeh R, et al. 2007. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 34:268-4.

Findik O, Aydin U, Baris O, et al. 2016. Preoperative low serum albumin levels increase the requirement of renal replacement therapy after cardiac surgery. Heart Surg Forum 19:E123-7.

Gardner TJ, Spray TL, eds. Operative Cardiac Surgery. 5th ed. London: Arnold; 2004.

Hobson CE, Yavas S, Segal MS, et al. 2009. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 119:2444–53.

Korantzopoulos P, Kolettis TM, Kountouris E, et al. 2005. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102:321-6.

Kouchoukos NT, Blackstone EH, Hanley FL, Kirklin JK. Kirklin/Barrat-Boyes Cardiac Surgery. 4th ed. Philadelphia: Elsevier; 2013.

Kramer RS, Herron CR, Groom RC, Brown JR. 2015. Acute kidney injury subsequent to cardiac surgery. JECT 47:16-28.

Lameire NH, Vanholder R. 2004. Pathophysiology of ischemic acute renal failure. Best Pract Res Clin Anaesthesiol 18:21-36.

Lassnigg A, Schmidlin D, Mouhieddine M, et al. 2004. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597-605.

Liano F, Pascual J. 1996. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid acute renal failure study group. Kidney International 50:811-8.

Melethil S, Mason WD, Chian-Jo C. 1986. Dose-dependent absorption and excretion of vitamin C in humans. Int J Pharm 31:83-9.

Mehta RL, Kellum JA, Shah SV, et al. 2007. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31.

Myles PS, Scheinkestel C. 1993. Renal failure after cardiac surgery: Pathophysiology, prevention and treatment. As J Cardiac Thorac Surg 2:140-4.

Nashef SAM, Roques F, Sharples LD, et al. 2012. EuroSCORE II. Eur J Cardiothorac Surg 41:734-45.

National Kidney Foundation. 2002. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition and Classification of Stages of Chronic Kidney Disease. Am J Kidney Dis 39:S46-75.

Ozcan AV, Sacar M, Aybek H, et al. 2007. The effects of iloprost and vitamin C on kidney as a remote organ after ischemia/reperfusion of lower extremities. J Surg Research 140:20-6.

Rababa’h AM, Deo SV, Altarabsheh SE, et al. 2016. N-acetyl cysteine therapy does not prevent renal failure in high-risk patients undergoing open-heart surgery. Heart Surg Forum 19:E16-22.

Rydén L, Ahnve S, Bell M, Hammar N, Ivert T, Holzmann MJ. 2012. Acute kidney injury following coronary artery bypass grafting: early mortality and postoperative complications. Scand Cardiovasc J 46:114-20.

Sadat U, Usman A, Gillard JH, Boyle JR. 2013. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials. J Am Coll Cardiol 62:2167-75.

Tekeli Kunt A, Parlar H, Findik O, Duzyol C, Baris O, Balci C. 2016. The influence of metabolic syndrome on acute kidney injury occurrence after coronary artery bypass grafting. Heart Surg Forum 19:E099-103.

Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB. 2006. Biomarkers of acute renal injury and renal failure. Shock 26:245-53.

Zhou L, Chen H. 2012. Prevention of contrast-induced nephropathy with ascorbic acid. Intern Med 51:531-5.



How to Cite

Antonic, M. (2017). Effect of Ascorbic Acid on Postoperative Acute Kidney Injury in Coronary Artery Bypass Graft Patients: A Pilot Study. The Heart Surgery Forum, 20(5), E214-E218. https://doi.org/10.1532/hsf.1811